1. Product Overview & Specifications

2. Key Applications

This compound serves as a critical intermediate in pharmaceutical synthesis, particularly in the production of gefitinib, a tyrosine kinase inhibitor used in cancer therapy. Its structural properties enable:

• Precision in API (Active Pharmaceutical Ingredient) manufacturing
• High-purity synthesis of quinazoline derivatives
• Development of targeted oncology medications

3. Usage Scenarios

Pharmaceutical Synthesis

Used under controlled conditions (GMP standards) for:

• Multi-step organic reactions requiring methoxy-group stability
• Catalytic hydrogenation processes
• Purification via recrystallization (ethanol/water systems)

4. Client Case Studies

Case 1: Oncology Drug Development

Client: Beijing Lingbao Technology Co., Ltd.
Application: Synthesis of gefitinib impurities and intermediates
Outcome: Achieved 99.8% purity in final API batches, complying with ICH Q3A/B guidelines.

Case 2: Research Institute Collaboration

Client: Confidential (Major European Pharma)
Application: Development of novel kinase inhibitors
Outcome: Accelerated lead optimization phase by 40% through improved synthetic routes.

5. Contact for Technical Support

For analytical certificates, bulk pricing, or custom synthesis requirements: